Biotech and Fintech Firms Face Investor Lawsuits Over Financial Disclosures

San Diego, Thursday, 18 June 2026.
Two high-profile companies—Erasca, a cancer therapy developer, and PicS, a fintech firm—are battling investor lawsuits alleging misleading financial statements. Erasca’s market value plummeted by $2.8 billion after a patient death and intellectual property concerns, while PicS faces accusations of omitting critical credit risks in its IPO documents. Investors claim these disclosures led to massive losses, with PicS shares dropping over 50% since its January 2026 IPO. The lawsuits underscore heightened scrutiny in high-risk sectors, where regulatory complexities and financial transparency are under the microscope.